Skip to content
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Newsroom
First
Prev
6
7
8
9
10
Next
Last
GMP Requirements for Clinical Trial Material: An Overview
Dec 22, 2021 12:00:00 AM
Biologics CDMO: What It Is & Why You Need One in This Market
Dec 8, 2021 12:00:00 AM
Accelerating the Biologics Development Process
Nov 24, 2021 12:00:00 AM
Aseptic Pharmaceutical Manufacturing: How It Works
Nov 17, 2021 12:00:00 AM
Formulation Development: Why It’s So Important
Nov 10, 2021 12:00:00 AM
Understanding Emulsion Formulation
Nov 8, 2021 12:00:00 AM
Sterile Injectable Drugs Defined
Nov 3, 2021 12:00:00 AM
Biologics vs. Small Molecule Drugs: Which Are Better?
Oct 27, 2021 12:00:00 AM
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Oct 12, 2021 12:00:00 AM
Ascendia to Highlight CDMO Services at AAPS PharmSci360
Oct 7, 2021 12:00:00 AM
Development and Scale Up Considerations for Nanosuspension Dosage Forms
Sep 13, 2021 12:00:00 AM
How to Successfully Utilize ASDs for Drug Delivery of Insoluble Drugs
Aug 20, 2021 12:00:00 AM